ESPR
$6.68
Esperion Theraptc
$.03
.45%
ESPR
Earnings Whisper ®
N/A
4th Quarter December 2022
Consensus:  ($0.87)
Revenue:  $19.79 Mil
Tuesday
Feb 21
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ESPR reports earnings?
Beat
Meet
Miss

Where is ESPR's stock price going from here?
Up
Flat
Down
Stock chart of ESPR
Analysts
Summary of analysts' recommendations for ESPR
Score
Grade
Pivots
Resistance
$7.16
$7.02
$6.85

$6.71

Support
$6.54
$6.40
$6.23
Tweet
Growth
Description
Esperion Therapeutics, Inc. is a biopharmaceutical company. It focused on the research, development and commercialization of therapies for low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion Therapeutics, Inc. is based in Plymouth, Michigan.
Peers
Regeneron PharmaceuticalsVertex PharmaceuticalsBristol-Myers SquibbJohnson & JohnsonEli LillyMerck & Co.Ultragenyx PharmaceuticalBioMarin PharmaceuticalArray TechnologiesUnited Therapeutics